Stine Friis

Director, Head Of Business Development at Evaxion Biotech

Stine Friis began their career in 2007 as a Research Assistant at the University of Copenhagen. Stine then became a PhD Student at the same university in the same year, where they analyzed the spatial separation of matriptase and prostasin in polarized epithelium. Stine subsequently became a Visiting PhD Student at the National Institutes of Health in 2010 and 2011. In 2011, they became a Post Doc at the National Institutes of Health, where they focused on the mechanisms that activate and inhibit the two serine proteases matriptase and prostasin. In 2014, they became an Assistant Professor at the University of Copenhagen. In 2018, they joined Evaxion Biotech A/S, where they have held the roles of Director of preclinical studies in immuno-oncology, Senior Project Manager of preclinical studies, and Project Manager of preclinical studies.

Stine Friis obtained a Doctor of Philosophy (PhD) in Molecular Biology from Københavns Universitet - University of Copenhagen between 2008 and 2011. Stine also obtained a B.Sc. and M.Sc. in Molecular Medicine and Biology-Biotechnology from the same university between 2002 and 2011.

Location

Hørsholm, Denmark

Links

Previous companies


Org chart


Teams


Offices


Evaxion Biotech

7 followers

Evaxion is pioneering the field of immunoinformatics, working hard to bring novel, highly effective vaccines and antibodies to patients. By converting complex immunological data into computational algorithms, Evaxion is capable of programming the immune system to fight off a variety of diseases from cancers to hard-to-treat anti-microbial resistant infections.


Industries

Employees

51-200

Links